169 related articles for article (PubMed ID: 22404301)
1. Synthesis and discovery of N-carbonylpyrrolidine- or N-sulfonylpyrrolidine-containing uracil derivatives as potent human deoxyuridine triphosphatase inhibitors.
Miyakoshi H; Miyahara S; Yokogawa T; Chong KT; Taguchi J; Endoh K; Yano W; Wakasa T; Ueno H; Takao Y; Nomura M; Shuto S; Nagasawa H; Fukuoka M
J Med Chem; 2012 Apr; 55(7):2960-9. PubMed ID: 22404301
[TBL] [Abstract][Full Text] [Related]
2. Discovery of a novel class of potent human deoxyuridine triphosphatase inhibitors remarkably enhancing the antitumor activity of thymidylate synthase inhibitors.
Miyahara S; Miyakoshi H; Yokogawa T; Chong KT; Taguchi J; Muto T; Endoh K; Yano W; Wakasa T; Ueno H; Takao Y; Fujioka A; Hashimoto A; Itou K; Yamamura K; Nomura M; Nagasawa H; Shuto S; Fukuoka M
J Med Chem; 2012 Apr; 55(7):2970-80. PubMed ID: 22339362
[TBL] [Abstract][Full Text] [Related]
3. Discovery of highly potent human deoxyuridine triphosphatase inhibitors based on the conformation restriction strategy.
Miyahara S; Miyakoshi H; Yokogawa T; Chong KT; Taguchi J; Muto T; Endoh K; Yano W; Wakasa T; Ueno H; Takao Y; Fujioka A; Hashimoto A; Itou K; Yamamura K; Nomura M; Nagasawa H; Shuto S; Fukuoka M
J Med Chem; 2012 Jun; 55(11):5483-96. PubMed ID: 22607122
[TBL] [Abstract][Full Text] [Related]
4. 1,2,3-Triazole-containing uracil derivatives with excellent pharmacokinetics as a novel class of potent human deoxyuridine triphosphatase inhibitors.
Miyakoshi H; Miyahara S; Yokogawa T; Endoh K; Muto T; Yano W; Wakasa T; Ueno H; Chong KT; Taguchi J; Nomura M; Takao Y; Fujioka A; Hashimoto A; Itou K; Yamamura K; Shuto S; Nagasawa H; Fukuoka M
J Med Chem; 2012 Jul; 55(14):6427-37. PubMed ID: 22715973
[TBL] [Abstract][Full Text] [Related]
5. Acyclic nucleoside analogues as inhibitors of Plasmodium falciparum dUTPase.
Nguyen C; Ruda GF; Schipani A; Kasinathan G; Leal I; Musso-Buendia A; Kaiser M; Brun R; Ruiz-Pérez LM; Sahlberg BL; Johansson NG; Gonzalez-Pacanowska D; Gilbert IH
J Med Chem; 2006 Jul; 49(14):4183-95. PubMed ID: 16821778
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and biological evaluation of novel uracil derivatives bearing 1, 2, 3-triazole moiety as thymidylate synthase (TS) inhibitors and as potential antitumor drugs.
Lu GQ; Li XY; Mohamed O K; Wang D; Meng FH
Eur J Med Chem; 2019 Jun; 171():282-296. PubMed ID: 30927565
[TBL] [Abstract][Full Text] [Related]
7. Small interfering RNA-mediated suppression of dUTPase sensitizes cancer cell lines to thymidylate synthase inhibition.
Koehler SE; Ladner RD
Mol Pharmacol; 2004 Sep; 66(3):620-6. PubMed ID: 15322254
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and evaluation of novel uracil acetamide derivatives as potential inhibitors of Plasmodium falciparum dUTP nucleotidohydrolase.
McCarthy O; Musso-Buendia A; Kaiser M; Brun R; Ruiz-Perez LM; Johansson NG; Pacanowska DG; Gilbert IH
Eur J Med Chem; 2009 Feb; 44(2):678-88. PubMed ID: 18619713
[TBL] [Abstract][Full Text] [Related]
9. Deoxyuridine triphosphatase (dUTPase) expression and sensitivity to the thymidylate synthase (TS) inhibitor ZD9331.
Webley SD; Hardcastle A; Ladner RD; Jackman AL; Aherne GW
Br J Cancer; 2000 Sep; 83(6):792-9. PubMed ID: 10952785
[TBL] [Abstract][Full Text] [Related]
10. dUTPase inhibition confers susceptibility to a thymidylate synthase inhibitor in DNA-repair-defective human cancer cells.
Yokogawa T; Yano W; Tsukioka S; Osada A; Wakasa T; Ueno H; Hoshino T; Yamamura K; Fujioka A; Fukuoka M; Ohkubo S; Matsuo K
Cancer Sci; 2021 Jan; 112(1):422-432. PubMed ID: 33140501
[TBL] [Abstract][Full Text] [Related]
11. The role of dUTPase and uracil-DNA repair in cancer chemotherapy.
Ladner RD
Curr Protein Pept Sci; 2001 Dec; 2(4):361-70. PubMed ID: 12374095
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and high-throughput evaluation of triskelion uracil libraries for inhibition of human dUTPase and UNG2.
Jiang YL; Chung S; Krosky DJ; Stivers JT
Bioorg Med Chem; 2006 Aug; 14(16):5666-72. PubMed ID: 16678429
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of 5-fluoro-2'-deoxyuridine antineoplastic activity by 5-benzyloxybenzyloxybenzylacyclouridine in a human colon carcinoma cell line.
Chu E; Chu MY; Darnowski JW; Chen ZH; Pan BC; Chu SH
Cancer Res; 1992 Apr; 52(7):1729-36. PubMed ID: 1532344
[TBL] [Abstract][Full Text] [Related]
14. [QSAR-modeling of desoxyuridine triphosphatase inhibitors in a series of some derivatives of uracil].
Martynova YZ; Khairullina VR; Gimadieva AR; Mustafin AG
Biomed Khim; 2019 Feb; 65(2):103-113. PubMed ID: 30950815
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological properties of novel, uracil-containing histone deacetylase inhibitors.
Mai A; Massa S; Rotili D; Simeoni S; Ragno R; Botta G; Nebbioso A; Miceli M; Altucci L; Brosch G
J Med Chem; 2006 Oct; 49(20):6046-56. PubMed ID: 17004718
[TBL] [Abstract][Full Text] [Related]
16. Structure/function analysis of a dUTPase: catalytic mechanism of a potential chemotherapeutic target.
Harris JM; McIntosh EM; Muscat GE
J Mol Biol; 1999 Apr; 288(2):275-87. PubMed ID: 10329142
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of novel 1H-1,2,3-triazole tethered C-5 substituted uracil-isatin conjugates and their cytotoxic evaluation.
Kumar K; Sagar S; Esau L; Kaur M; Kumar V
Eur J Med Chem; 2012 Dec; 58():153-9. PubMed ID: 23124212
[TBL] [Abstract][Full Text] [Related]
18. Structure-based design of lipophilic quinazoline inhibitors of thymidylate synthase.
Jones TR; Varney MD; Webber SE; Lewis KK; Marzoni GP; Palmer CL; Kathardekar V; Welsh KM; Webber S; Matthews DA; Appelt K; Smith WW; Janson CA; Villafranca JE; Bacquet RJ; Howland EF; Booth CL; Herrmann SM; Ward RW; White J; Moomaw EW; Bartlett CA; Morse CA
J Med Chem; 1996 Feb; 39(4):904-17. PubMed ID: 8632414
[TBL] [Abstract][Full Text] [Related]
19. Medicinal chemistry aspects of uracil containing dUTPase inhibitors targeting colorectal cancer.
Backer N; Kumar A; Singh AK; Singh H; Narasimhan B; Kumar P
Drug Discov Today; 2024 Jan; 29(1):103853. PubMed ID: 38070703
[TBL] [Abstract][Full Text] [Related]
20. 5-Aryluracils as potent GnRH antagonists-Characterization of atropisomers.
Zhao L; Guo Z; Chen Y; Hu T; Wu D; Zhu YF; Rowbottom M; Gross TD; Tucci FC; Struthers RS; Xie Q; Chen C
Bioorg Med Chem Lett; 2008 Jun; 18(11):3344-9. PubMed ID: 18442905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
